|
|
|
|
|
HONG KONG, Mar 1, 2018 - (Media OutReach) - XPENG Motors, a leading Chinese electric vehicle company, today announced that Dr. Brian Gu has been appointed as Vice Chairman and President. Dr. Gu will report directly to He Xiaopeng, Chairman of XPENG Motors, and will lead XPENG's global strategy, finance, fundraising, investments and international partnerships.
 | | XPENG Motors Appoints Dr. Brian Gu as Vice Chairman and President |
Dr. Brian Gu most recently served as Chairman of Asia Pacific Investment Banking for J.P. Morgan and is a member of J.P. Morgan's Global Strategic Advisory Council. Dr. Gu joined J.P. Morgan in 2004 and has held a variety of leadership roles instrumental in building J.P. Morgan's franchise in the Asia Pacific region.
"I am very excited to welcome Dr. Gu on board as a part of XPENG Motors' leadership team. While the market opportunity for internet-connected electric vehicles is tremendous, capitalizing on that opportunity requires an all-star leadership team to move the Company forward," He Xiaopeng, Chairman of XPENG Motors said, "Strong financing, independent innovation and high-quality manufacturing are three critical pillars for XPENG's future growth. Dr. Gu's deep experience in technology, finance and global strategy make him a perfect fit to help the Company take the next step in its growth."
XPENG Motors is accelerating its growth this year with the announcement of its latest model, the G3, in January at the Consumer Electronics Show in Las Vegas. The flagship model is designed to appeal to China's new generation of young consumers that embrace an attitude of both exploration and innovation.
Dr. Gu said: "The internet and new technology are disrupting traditional industries worldwide and new companies that embrace innovation at their core are winning across the globe. XPENG is one of the new global champions because it is embracing the use of artificial intelligence and new electric vehicle technology to tackle China's transportation challenge. I look forward to joining XPENG's leadership team and helping to pave the way for its next chapter of growth and innovation."
Dr. Gu brings two decades of experience advising global multinational companies, as well as China's most prominent technology companies and entrepreneurs. Before joining J.P. Morgan, Dr. Gu worked in the global M&A and global healthcare practice of Lehman Brothers in New York from 1998 to 2004. Prior to his Wall Street career, Dr. Gu was a senior research scientist at the University of Washington Medical School. He holds an MBA from Yale University, a Ph.D. in Biochemistry from the University of Washington Medical School and a bachelor's degree in Chemistry from the University of Oregon.
About XPENG Motors
XPENG Motors is a leading Chinese electric vehicle company that designs and manufactures automobiles that are seamlessly integrated with the internet and utilize the latest advances in artificial intelligence. The company's initial backers include its chairman He Xiaopeng, the founder of UCWeb Inc. and a former Alibaba executive. It was co-founded in 2014 by Henry Xia and He Tao, former senior executives at Guangzhou Auto with expertise in innovative automotive technology and R&D. It has received funding from prominent Chinese and international investors including Alibaba Group, Foxconn Group, and IDG Capital. XPENG Motors is headquartered in Guangzhou, China. For more information, please visit the official website of XPENG Motors at: https://www.xiaopeng.com
Media enquiries:
Spoon Communications
Tiffany Chan
Email: tiffany@tks-partners.com
Phone: +852 6650 2360
Ceci Chan
Email: ceci@tks-partners.com
Phone: +852 9279 3516
Topic: Press release summary
Source: XPENG Motors
Sectors: Enterprise IT, CyberSecurity, Digitalization
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
Latest Press Releases
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership 
Monday, December 15, 2025 7:30:00 AM
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Friday, December 12, 2025 10:15:00 PM
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Friday, December 12, 2025 10:00:00 AM
|
|
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT/SGT
|
|
|
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing
Dec 11, 2025 18:09 HKT/SGT
|
|
|
Nasdaq Verafin Joins Global Anti-Scam Alliance
Dec 11, 2025 14:21 HKT/SGT
|
|
|
Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards
Dec 11, 2025 12:54 HKT/SGT
|
|
|
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating
Dec 11, 2025 08:20 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
